Data / Form D filings / Cellanome, Inc.
Cellanome, Inc.: Form D filings
Cellanome, Inc., a biotechnology company in Foster City, CA, filed 6 Form D notices with the SEC between 2021 and 2026. The latest, on June 22, 2026, reports $75.9 million sold of a $75.9 million offering to 22 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 500 Lincoln Centre Dr., 3rd Floor, Foster City, CA, 94404
- Phone
- (650) 407-5414
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1886462
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | New notice | $75,930,476 | $75,930,476 | 22 | Dec 23, 2025 | sec.gov | |
| Jan 29, 2024 | New notice | $149,999,997 | $149,999,997 | 20 | Dec 4, 2023 | sec.gov | |
| Mar 21, 2023 | Amendment | $40,664,711 | $40,664,711 | 11 | Jul 25, 2022 | sec.gov | |
| Aug 5, 2022 | New notice | $29,999,994 | $29,957,106 | $42,888 | 10 | Jul 25, 2022 | sec.gov |
| Dec 6, 2021 | New notice | $20,999,996 | $20,999,996 | 2 | Nov 22, 2021 | sec.gov | |
| Oct 5, 2021 | New notice | $2,049,990 | $2,049,990 | 17 | Sep 17, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Omead Ostadan | Executive Officer, Director | |
| Rowan Chapman | Director | |
| Mostafa Ronaghi | Director | |
| Jay Flatley | Director | |
| Sandesh Patnam | Director | |
| Mehdi Khodadad | Executive Officer | Secretary |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 22, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Cellanome, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.